| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.097 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |